Abadi AJ, Zarrabi A, Gholami MH, Mirzaei S, Hashemi F, Zabolian A, Entezari M, Hushmandi K, Ashrafizadeh M, Khan H (2021) Small in size, but large in action: microRNAs as potential modulators of PTEN in breast and lung cancers. Biomolecules 11:304
Article CAS PubMed PubMed Central Google Scholar
Abusaiba THH, Hussein AA (2024) microRNA Biogenesis, Mechanisms of Actions and Circulation. Qeios 4:(1–8)
Alnuqaydan AM (2020) Targeting micro-RNAs by natural products: A novel future therapeutic strategy to combat cancer. Am J Transl Res 12:3531
CAS PubMed PubMed Central Google Scholar
Asgharian P, Tazekand AP, Hosseini K, Forouhandeh H, Ghasemnejad T, Ranjbar M, Hasan M, Kumar M, Beirami SM, Tarhriz V (2022) Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int 22:257
Article CAS PubMed PubMed Central Google Scholar
Ashrafizadeh M, Zarrabi A, Orouei S, Hushmandi K, Hakimi A, Zabolian A, Daneshi S, Samarghandian S, Baradaran B, Najafi M (2021a) MicroRNA-mediated autophagy regulation in cancer therapy: the role in chemoresistance/chemosensitivity. Eur J Pharmacol 892:173660
Article CAS PubMed Google Scholar
Ashrafizadeh M, Zarrabi A, Orouei S, Zabolian A, Saleki H, Azami N, Bejandi AK, Mirzaei S, Janaghard MN, Hushmandi K (2021b) Interplay between SOX9 transcription factor and microRNAs in cancer. Int J Biol Macromol 183:681–694
Article CAS PubMed Google Scholar
Bautista-Sánchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Velázquez IA, González-Barrios R, Contreras-Espinosa L, Montiel-Manríquez R, Castro-Hernández C, Fragoso-Ontiveros V, Álvarez-Gómez RM (2020) The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Mol Ther-Nucleic Acids 20:409–420
Article PubMed PubMed Central Google Scholar
Bhattacharyya A, Kumar H, Mishra P, Panda A, Dash K, Adhikary T (2023) CRISPR technology-a new horizon in clinical dentistry-a review. Bangladesh J Med Sci 22:42–46
Bloebaum M, Poort L, Böckmann R, Kessler P (2014) Survival after curative surgical treatment for primary oral squamous cell carcinoma. J Cranio-Maxillofac Surg 42:1572–1576
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 74:229–263
Chai AWY, Yee PS, Price S, Yee SM, Lee HM, Tiong VK, Gonçalves E, Behan FM, Bateson J, Gilbert J (2020) Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway. Elife 9:e57761
Article CAS PubMed PubMed Central Google Scholar
Chattopadhyay E, Singh R, Ray A, Roy R, De Sarkar N, Paul RR, Pal M, Aich R, Roy B (2016) Expression deregulation of mir31 and CXCL12 in two types of oral precancers and cancer: Importance in progression of precancer and cancer. Sci Rep 6:32735
Article CAS PubMed PubMed Central Google Scholar
Chen J-H, Wu AT, Bamodu OA, Yadav VK, Chao T-Y, Tzeng Y-M, Mukhopadhyay D, Hsiao M, Lee J-C (2019) Ovatodiolide suppresses oral cancer malignancy by down-regulating exosomal Mir-21/STAT3/β-catenin cargo and preventing oncogenic transformation of normal gingival fibroblasts. Cancers 12:56
Article PubMed PubMed Central Google Scholar
Deng Z, Lu L, Li B, Shi X, Jin H, Hu W (2023) The roles of inflammasomes in cancer. Front Immunol 14:1195572
Article CAS PubMed PubMed Central Google Scholar
Dinesh Y, Ramani P, Yuwanati M, Ramalingam K, Gheena S (2023) MicroRNA profiling in circulating exosomes in oral squamous cell carcinoma: a systematic review. Cureus 15:1–13
Doghish AS, El-Husseiny AA, Khidr EG, Elrebehy MA, Elballal MS, Abdel-Reheim MA, Mageed SSA, Zaki MB, Mohammed OA, Khaled R (2023a) Decoding the role of miRNAs in oral cancer pathogenesis: A focus on signaling pathways. Pathol-Res Pract 252:1–14
Doghish AS, Elshaer SS, Fathi D, Rizk NI, Elrebehy MA, Al-Noshokaty TM, Elballal MS, Abdelmaksoud NM, Abdel-Reheim MA, Mageed SSA (2023b) Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of oral cancer. Pathol-Res Pract 253:1–26
Elballal MS, Sallam A-AM, Elesawy AE, Shahin RK, Midan HM, Elrebehy MA, Elazazy O, El-Boghdady RM, Blasy SH, Amer NM (2023) miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses. Pathol-Res Pract 245:154439
Article CAS PubMed Google Scholar
El-Husseiny AA, Abdelmaksoud NM, Mageed SSA, Salman A, Zaki MB, El-Mahdy HA, Ismail A, Abd-Elmawla MA, El-Husseiny HM, Abulsoud AI (2023) miRNAs orchestration of salivary gland cancer-Particular emphasis on diagnosis, progression, and drug resistance. Pathol-Res Pract 248:154590
Article CAS PubMed Google Scholar
Eslami M, Khazeni S, Khanaghah XM, Asadi MH, Ansari MA, Garjan JH, Lotfalizadeh MH, Bayat M, Taghizadieh M, Taghavi SP (2023) MiRNA-related metastasis in oral cancer: moving and shaking. Cancer Cell Int 23:182
Article CAS PubMed PubMed Central Google Scholar
Feng Y-H, Tsao C-J (2016) Emerging role of microRNA-21 in cancer. Biomed Rep 5:395–402
Article CAS PubMed PubMed Central Google Scholar
Feng X, Luo Q, Wang H, Zhang H, Chen F (2018) MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3. J Cell Physiol 233:6705–6713
Article CAS PubMed Google Scholar
Garajei A, Allameh A, Azadi M, Emami A, Atashbasteh M, Mostafavi M, Ghaderi B, Inchingolo F, Sadeghi M, Tadakamadla SK (2023) Evaluation of the expression levels of miR-21-5p and miR-429 genes in biopsy samples from patients with oral squamous cell carcinoma. Diagnostics 13:1244
Article CAS PubMed PubMed Central Google Scholar
Geyer M, Geyer F, Reuning U, Klapproth S, Wolff K-D, Nieberler M (2024) CRISPR/Cas9-mediated knock out of ITGB6 in human OSCC cells reduced migration and proliferation ability. Head Face Med 20:37
Article CAS PubMed PubMed Central Google Scholar
Ghuwalewala S, Ghatak D, Das S, Roy S, Das P, Butti R, Gorain M, Nath S, Kundu GC, Roychoudhury S (2021) MiRNA-146a/AKT/β-catenin activation regulates cancer stem cell phenotype in oral squamous cell carcinoma by targeting CD24. Front Oncol 11:651692
Article CAS PubMed PubMed Central Google Scholar
Hosseini SA, Elahian F, Mirzaei SA (2024) Innovative genetic scissor strategies and their applications in cancer treatment and prevention: CRISPR modules and challenges. Int J Biol Macromol 279:1–8
Huang F, Xin C, Lei K, Bai H, Li J, Chen Q (2020) Noncoding RNAs in oral premalignant disorders and oral squamous cell carcinoma. Cell Oncol 43:763–777
Hussen BM, Rasul MF, Abdullah SR, Hidayat HJ, Faraj GSH, Ali FA, Salihi A, Baniahmad A, Ghafouri-Fard S, Rahman M (2023) Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges. Mil Med Res 10:32
CAS PubMed PubMed Central Google Scholar
Jameel ZI (2023) MicroRNA biogenesis, mechanisms of function, circulation and application role in human diseases. Int J Sci Res Biol Sci 10:71–80
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR (2020) Head and neck squamous cell carcinoma. Nat Rev Dis Primers 6:92
Article PubMed PubMed Central Google Scholar
Kao Y-Y, Chou C-H, Yeh L-Y, Chen Y-F, Chang K-W, Liu C-J, Chiang C-YF, Lin S-C (2019) MicroRNA miR-31 targets SIRT3 to disrupt mitochondrial activity and increase oxidative stress in oral carcinoma. Cancer Lett 456:40–48
Article CAS PubMed Google Scholar
Komatsu S, Kitai H, Suzuki HI (2023) Network regulation of microRNA biogenesis and target interaction. Cells 12:306
留言 (0)